Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Michael Elliott Weinblatt, M.D.

Co-Author

This page shows the publications co-authored by Michael Weinblatt and Daniel Solomon.
Connection Strength

5.066
  1. Supplementing Claims Data with Electronic Medical Records to Improve Estimation and Classification of Rheumatoid Arthritis Disease Activity: A Machine Learning Approach. ACR Open Rheumatol. 2019 Nov; 1(9):552-559.
    View in: PubMed
    Score: 0.214
  2. Diet and Rheumatoid Arthritis Symptoms: Survey Results From a Rheumatoid Arthritis Registry. Arthritis Care Res (Hoboken). 2017 12; 69(12):1920-1925.
    View in: PubMed
    Score: 0.189
  3. Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement. Arthritis Res Ther. 2017 06 13; 19(1):130.
    View in: PubMed
    Score: 0.183
  4. Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries. BMC Med Res Methodol. 2017 Apr 17; 17(1):59.
    View in: PubMed
    Score: 0.181
  5. Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities. Arthritis Rheumatol. 2017 04; 69(4):720-727.
    View in: PubMed
    Score: 0.181
  6. Editorial: the vital role of randomized controlled trials in Arthritis & Rheumatology. Arthritis Rheumatol. 2015 Oct; 67(10):2555-6.
    View in: PubMed
    Score: 0.163
  7. The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs. Rheumatology (Oxford). 2015 Nov; 54(11):2076-84.
    View in: PubMed
    Score: 0.160
  8. Development of a multimorbidity index: Impact on quality of life using a rheumatoid arthritis cohort. Semin Arthritis Rheum. 2015 Oct; 45(2):167-73.
    View in: PubMed
    Score: 0.160
  9. Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis. J Rheumatol. 2014 Dec; 41(12):2370-8.
    View in: PubMed
    Score: 0.152
  10. Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs. Semin Arthritis Rheum. 2015 Feb; 44(4):399-404.
    View in: PubMed
    Score: 0.151
  11. Rheumatoid arthritis quality measures and radiographic progression. Semin Arthritis Rheum. 2014 Aug; 44(1):9-13.
    View in: PubMed
    Score: 0.145
  12. Flares in rheumatoid arthritis: frequency and management. A report from the BRASS registry. J Rheumatol. 2014 Feb; 41(2):227-34.
    View in: PubMed
    Score: 0.144
  13. Response to: 'Biologic discontinuation studies: a systematic review of methods' by van der Maas et al. Ann Rheum Dis. 2014 Jan; 73(1):e5.
    View in: PubMed
    Score: 0.142
  14. Use of data from multiple registries in studying biologic discontinuation: challenges and opportunities. Clin Exp Rheumatol. 2013 Jul-Aug; 31(4 Suppl 78):S28-32.
    View in: PubMed
    Score: 0.142
  15. Biologic discontinuation studies: a systematic review of methods. Ann Rheum Dis. 2014 Mar; 73(3):595-9.
    View in: PubMed
    Score: 0.139
  16. Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Apr; 65(4):526-33.
    View in: PubMed
    Score: 0.137
  17. Increasing pneumococcal vaccination for immunosuppressed patients: a cluster quality improvement trial. Arthritis Rheum. 2013 Jan; 65(1):39-47.
    View in: PubMed
    Score: 0.135
  18. Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis Res Ther. 2012 Mar 19; 14(2):R68.
    View in: PubMed
    Score: 0.127
  19. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis. 2012 May; 71(5):681-6.
    View in: PubMed
    Score: 0.124
  20. Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther. 2011 Jun 08; 13(3):R83.
    View in: PubMed
    Score: 0.121
  21. The end of rheumatoid factor as we know it? Arthritis Rheum. 2011 May; 63(5):1170-2.
    View in: PubMed
    Score: 0.120
  22. Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study. Rheumatology (Oxford). 2011 Aug; 50(8):1473-9.
    View in: PubMed
    Score: 0.119
  23. Validation of rheumatoid arthritis diagnoses in health care utilization data. Arthritis Res Ther. 2011 Feb 23; 13(1):R32.
    View in: PubMed
    Score: 0.118
  24. Hand bone mineral density is associated with both total hip and lumbar spine bone mineral density in post-menopausal women with RA. Rheumatology (Oxford). 2010 Mar; 49(3):513-9.
    View in: PubMed
    Score: 0.109
  25. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 2009 Jun; 60(6):1624-31.
    View in: PubMed
    Score: 0.105
  26. Development of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary study. Arthritis Res Ther. 2008; 10(4):R95.
    View in: PubMed
    Score: 0.099
  27. Predictors of discontinuation of tumor necrosis factor inhibitors in patients with rheumatoid arthritis. J Rheumatol. 2008 Sep; 35(9):1737-44.
    View in: PubMed
    Score: 0.099
  28. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis. Am Heart J. 2008 Aug; 156(2):336-41.
    View in: PubMed
    Score: 0.098
  29. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum. 2007 Aug 15; 57(6):928-34.
    View in: PubMed
    Score: 0.093
  30. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum. 2007 Jun; 56(6):1754-64.
    View in: PubMed
    Score: 0.091
  31. Agreement between patient report and medical record review for medications used for rheumatoid arthritis: the accuracy of self-reported medication information in patient registries. Arthritis Rheum. 2007 Mar 15; 57(2):234-9.
    View in: PubMed
    Score: 0.090
  32. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Dec; 54(12):3790-8.
    View in: PubMed
    Score: 0.088
  33. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis. 2006 Dec; 65(12):1608-12.
    View in: PubMed
    Score: 0.086
  34. The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28. Arthritis Res Ther. 2006; 8(3):R57.
    View in: PubMed
    Score: 0.084
  35. Performance of a rheumatoid arthritis records-based index of severity. J Rheumatol. 2005 Sep; 32(9):1679-87.
    View in: PubMed
    Score: 0.081
  36. Development and assessment of indicators of rheumatoid arthritis severity: results of a Delphi panel. Arthritis Rheum. 2005 Feb 15; 53(1):61-6.
    View in: PubMed
    Score: 0.078
  37. Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis. PLoS One. 2019; 14(8):e0221314.
    View in: PubMed
    Score: 0.053
  38. Prevalence and predictors for sustained remission in rheumatoid arthritis. PLoS One. 2019; 14(4):e0214981.
    View in: PubMed
    Score: 0.052
  39. Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis. Arthritis Rheumatol. 2018 09; 70(9):1392-1398.
    View in: PubMed
    Score: 0.050
  40. An external validation study reporting poor correlation between the claims-based index for rheumatoid arthritis severity and the disease activity score. Arthritis Res Ther. 2015 Apr 13; 17:83.
    View in: PubMed
    Score: 0.039
  41. Behavioral and clinical factors associated with self-reported abnormal Papanicolaou tests in rheumatoid arthritis. J Womens Health (Larchmt). 2014 Sep; 23(9):771-6.
    View in: PubMed
    Score: 0.038
  42. Routinely measuring and reporting pneumococcal vaccination among immunosuppressed rheumatology outpatients: the first step in improving quality. Rheumatology (Oxford). 2011 Feb; 50(2):366-72.
    View in: PubMed
    Score: 0.029
  43. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology (Oxford). 2011 Jan; 50(1):40-6.
    View in: PubMed
    Score: 0.029
  44. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2010 Aug; 62(8):2239-48.
    View in: PubMed
    Score: 0.028
  45. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. Semin Arthritis Rheum. 2010 Aug; 40(1):2-14.e1.
    View in: PubMed
    Score: 0.028
  46. TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma. J Clin Rheumatol. 2009 Jun; 15(4):198-200.
    View in: PubMed
    Score: 0.026
  47. Opposing effects of the D70 mutation and the shared epitope in HLA-DR4 on disease activity and certain disease phenotypes in rheumatoid arthritis. Ann Rheum Dis. 2007 Nov; 66(11):1497-502.
    View in: PubMed
    Score: 0.023
  48. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum. 2006 Sep; 54(9):2757-64.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.